Presentations Seminar 1

Please click here to find the correct answers to the self-assessment survey (to be uploaded). 

Presentations (to be uploaded after the seminar): 

1. Therapeutic drug monitoring for all drugs and for all patients?
Dr Ute Blassmann, Heidelberg University Hospital, Germany

2. Do we need therapeutic drug monitoring for beta lactams or can we just use prolonged infusions?
Dr Ute Blassmann, Heidelberg University Hospital, Germany

3. MIC directed therapy: why, when and what are the pitfalls? 

4. The impact of PK/PD for clinical decisions 

5. Interactive Part – clinical cases – PK/PD
Prof Dr Isabel Spriet, UZ Leuven, Belgium
Dr Peter Declercq, University Hospitals Leuven, Belgium

6. Interactive Part – OPAT, guidelines
Prof Dr Isabel Spriet, UZ Leuven, Belgium
Tine Van Nieuwenhuyse, UZ Leuven, Belgium 

7. Antifungal therapy: what comes out of the pipeline in the near future?
Prof William Hope*, University of Liverpool, United Kingdom

8. TDM and PK/PD in antifungal therapy: when and why?
Prof William Hope*, University of Liverpool, United Kingdom

9. Antimicrobial prophylaxis in HSCT-patients: guidelines and evidence
Dr Philipp Wohlfarth, Medical University of Vienna, Austria

10. Hygiene measures, isolation and therapy
Prof Dr Annette Schuermans, University Hospitals Leuven, Belgium

11. What’s really new in antibiotic therapy
Prof Dr Martin J. Hug, Institute of Pharmaceutical Sciences, University of Freiburg, Germany

12. Interactive Part
Prof Dr Isabel Spriet, UZ Leuven, Belgium
Prof William Hope*, University of Liverpool, United Kingdom

Last update: 3 July 2019